Literature DB >> 29215479

Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease.

James W T Toh1,2, Nelson Wang2, Christopher J Young2,3, Matthew J F X Rickard2, Anil Keshava2, Peter Stewart2, Viraj Kariyawasam4, Rupert Leong4.   

Abstract

BACKGROUND: Most patients with Crohn's disease still require surgery despite significant advances in medical therapy, surveillance, and management strategies.
OBJECTIVE: The purpose of this study was to assess surgical strategies and outcomes in Crohn's disease, including surgical recurrence and emergency surgery.
DESIGN: This was a multicenter, retrospective review of a prospectively collected database. SETTINGS: A specialist-referred cohort of patients with Crohn's disease between 1970 and 2009 was studied. PATIENTS: Included were 972 patients with Crohn's disease who were referred to the Sydney Inflammatory Bowel Disease cohort database. MAIN OUTCOME MEASURES: Main outcomes of interest were the rates of major abdominal and perianal surgery between decades (1970-1979, 1980-1989, 1990-1999, and 2000-2009), indications for surgery, types of procedure performed, rate of elective and emergency surgery, risk of surgical recurrence, and predictive factors for surgery.
RESULTS: Between 1970 and 2009, the overall risks of surgery within 5, 10, and 15 years of diagnosis were 31.7%, 43.3%, and 48.4%. The median time to first surgery from time of diagnosis was 2 years (range, 0-31 years). A total of 6.7% of patients required emergency surgery within 5 years of diagnosis. In total, 8.8% of patients required emergency surgery within 15 years. The overall risk of surgical recurrence was 35.9%. The risk of major abdominal surgery significantly decreased between 2000 and 2009 when compared with the 1970 to 1979 period (OR = 0.49 (95% CI, 0.34-0.70). However, the rate of perianal surgery significantly increased (OR = 5.76 (95% CI, 2.54-13.06)). The main indications for surgery were enteric stricture or obstruction, perianal disease, and intra-abdominal fistulas/abscess. Of the 972 patients over 4 decades, only 11 patients (1.1%) were diagnosed with colorectal cancer. LIMITATIONS: This was a specialist-referred cohort, not a population-based study.
CONCLUSIONS: The rate of major abdominal surgery has decreased, with surgery reserved for more severe and complicated disease. The natural history of patients with more complicated Crohn's disease and severe phenotypes puts them at higher risk of surgical recurrence and emergency surgery. There has been no reduction in emergency surgery rates and there has been an increase in surgical recurrence despite the reduction in surgical rate morbidity. See Video Abstract at http://links.lww.com/DCR/A483.

Entities:  

Mesh:

Year:  2018        PMID: 29215479     DOI: 10.1097/DCR.0000000000000975

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

1.  Risk factors for early postoperative complications and length of hospital stay in ileocecal resection and right hemicolectomy for Crohn's disease: a single-center experience.

Authors:  Christian Galata; Christel Weiss; Julia Hardt; Steffen Seyfried; Stefan Post; Peter Kienle; Karoline Horisberger
Journal:  Int J Colorectal Dis       Date:  2018-05-07       Impact factor: 2.571

2.  INFLAMMATORY BOWEL DISEASES: CHARACTERISTICS, EVOLUTION, AND QUALITY OF LIFE.

Authors:  Caique Moraes Mendonça; Isaac José Felippe Correa Neto; Alexander de Sá Rolim; Laercio Robles
Journal:  Arq Bras Cir Dig       Date:  2022-06-17

3.  Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis.

Authors:  Jurij Hanzel; Ahmed Almradi; Alexandra C Istl; Mei Lucy Yang; Katherine A Fleshner; Claire E Parker; Leonardo Guizzetti; Christopher Ma; Siddharth Singh; Vipul Jairath
Journal:  Dig Dis Sci       Date:  2021-02-26       Impact factor: 3.199

4.  Mesenteric granulomas independently predict long-term risk of surgical recurrence in Crohn's disease.

Authors:  L W Unger; S Argeny; A Stift; Y Yang; A Karall; T Freilinger; C Müller; M Bergmann; J Stift; S Riss
Journal:  Colorectal Dis       Date:  2019-08-23       Impact factor: 3.788

5.  Retrospective Study of Surgical Outcomes in 60 Patients with Crohn Disease from a Single Center in Poland.

Authors:  Karolina Majewska; Cezary Rusinowski; Beata Jabłońska; Dariusz Gołka; Sławomir Mrowiec
Journal:  Med Sci Monit       Date:  2022-01-12

6.  Tumour necrosis factor inhibitors in Crohn's disease and the effect on surgery rates.

Authors:  Michael Eberhardson; Pär Myrelid; Jonas K Söderling; Anders Ekbom; Åsa H Everhov; Charlotte R H Hedin; Martin Neovius; Jonas F Ludvigsson; Ola Olén
Journal:  Colorectal Dis       Date:  2022-01-22       Impact factor: 3.917

7.  A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.

Authors:  Susanna Meade; Kamal V Patel; Raphael P Luber; Dearbhaile O'Hanlon; Andra Caracostea; Polychronis Pavlidis; Sailish Honap; Cheran Anandarajah; Nyree Griffin; Sebastian Zeki; Shuvra Ray; Joel Mawdsley; Mark A Samaan; Simon H Anderson; Amir Darakhshan; Katie Adams; Andrew Williams; Jeremy D Sanderson; Miranda Lomer; Peter M Irving
Journal:  Aliment Pharmacol Ther       Date:  2022-06-20       Impact factor: 9.524

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.